Navigation Links
FDA OKs 1st Embryonic Stem Cell Trial
Date:1/23/2009

Might improve function in paralyzed patients, experts say

FRIDAY, Jan. 23 (HealthDay News) -- The first human trial using embryonic stem cells as a medical treatment has been approved by the U.S. Food and Drug Administration.

Geron Corp., a California-based biotech company, has been given the OK to implant embryonic stem cells in eight to 10 paraplegic patients who can use their arms but can't walk. Stem cell injections will be given within two weeks of the injury. The study will begin this summer, and will be conducted at up to seven different medical centers.

"This marks the dawn of a new era in medical therapeutics," Dr. Thomas B. Okarma, Geron's president and CEO said during a Friday morning teleconference. "This approach is one that reaches beyond pills and scalpels to achieve a new level of healing."

Ultimately, this type of therapy might have the power to restore permanent organ and tissue function, Okarma said. The goal of this first trial is to see if injecting embryonic stem cells into humans is safe. However, the researchers will also be looking for signs of improvement in the patients' ability to feel sensation in or move their legs.

Patients will receive injections at the site of the injury. It is hoped these cells will mature into cells that will repair damaged nerves and produce chemicals that nerve cells need to function and grow.

This phase I trial will be limited to patients whose injury is located in the middle of the spine. If the trial is successful, Okarma said, the hope is to extend the treatment to patients with cervical spine injuries who are paralyzed from the neck down.

Okarma said the injections must be given early after the injury, before scar tissue has developed that would prevent the cells from growing, but after the initial swelling has subsided.

In addition, patients will receive anti-rejection drugs for about two months, after which they sho
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Embryonic Stem Cells Repair Human Heart
2. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
3. Embryonic stem cells used to grow cartilage
4. Embryonic stem cells thrive when shaken
5. Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration
6. Study Probes Difference Between Embryonic, Adult Stem Cells
7. Serum carcinoembryonic antigen level can reflect adrenal adenoma
8. UC Davis researchers find evidence of mature heart cell potential in embryonic stem cells
9. Human embryonic stem cell lines created that avoid immune rejection
10. Embryonic Stem Cells Create Healthy Muscle in Mice
11. Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA OKs 1st Embryonic Stem Cell Trial
(Date:11/22/2014)... BambooFlooringChina.com is a famous brand in the bamboo ... collection of bamboo mats ; the new models are ... , According to the sales manager of BambooFlooringChina.com, Bamboo ... highly renewable resource. Their bamboo mats are 100% made from ... from natural bamboo with caramel bamboo strips. , ...
(Date:11/22/2014)... November 22, 2014 In order to provide ... promotion of cocktail party dresses. The business knows that a ... social occasions. , Now, the party dresses supplier’s ... 70% off. As the leading company in fashion industry, LunaDress ... outfit for every customer. So it always raises the professional ...
(Date:11/22/2014)... SATURDAY, Nov. 22, 2014 (HealthDay News) -- The wide ... can pose a threat for people with food allergies, ... there are so many types of food allergies that ... over the holidays," Dr. Guha Krishnaswamy, director of allergy ... said in a hospital news release. "If you ...
(Date:11/22/2014)... Recently, UWDress.com is gratified to introduce its new collection ... the company has also offered an attracting discount on ... supplier of wedding dresses, UWDress.com is good at manufacturing ... guest gowns are provided over 20 colors, which have ... is famous for high quality. Therefore, its sales increased ...
(Date:11/22/2014)... Developers and plugin specialist of Final Cut Pro ... Model bringing the impossible to FCPX from Pixel ... obj files to FCPX enabling 3d Model editing,” said Christina ... professional and armature, FCPX 3D Model is a definite game ... Cut Pro X users to upload and control 3D objects ...
Breaking Medicine News(10 mins):Health News:Trendy Bamboo Mats Online Now By BambooFlooringChina.com 2Health News:LunaDress Unveils Fabulous Cocktail Party Dresses 2Health News:'Tis the Season of Challenges for Those With Food Allergies 2Health News:Best Wedding Guest dresses Introduced by UWDress.com 2Health News:Pixel Film Studios released FCPX 3D Model plugin Exclusively for Final Cut Pro X 2
... ... and navigation enhancement XML API. , ... (PRWEB) May 27, 2010 -- Smartlogic has released a ... websites or in enterprise information management systems, using Semaphore,s search and navigation enhancement XML ...
... Helicobacter pylori , which lives in the human stomach ... like a corkscrew, or helix. For years researchers have hypothesized ... survive and thrive within the stomach,s acid-drenched environment, ... the first time, researchers at Fred Hutchinson Cancer Research Center ...
... Schrader had it all: steady job, a wife, and two ... morethat is, more children. Taking steps to keep his nuclear ... was back on the golf course the next afternoon. ... that followed Schrader would ultimately revisit the issue of having ...
... mood of those with sensitivities worsened when exposed to ... season may not mean just the inevitable coughing, sneezing ... , Researchers reported that finding at the American Psychiatric ... "Depression is a very common disorder and allergies are ...
... , ... announced that they have now added 7,000 stores in under five months of operation. The ... 100-200 new comments per day and 500 votes per day, making it one of the ... ...
... tying genes to common tumors may be invalid, researchers ... sample sizes may undercut the reliability of recent genome ... a Greek-American analysis cautions. , The observation is the ... harnessed technological innovations in so-called "whole genome sequencing" to ...
Cached Medicine News:Health News:Smartlogic Demonstrates Improved User Search, Find and Navigation with Semaphore Open Semantic Platform 2Health News:Shape matters: The corkscrew twist of H. pylori enables it to 'set up shop' in the stomach 2Health News:Shape matters: The corkscrew twist of H. pylori enables it to 'set up shop' in the stomach 3Health News:Robotic-assisted vasectomy reversal offers greater chance of fatherhood 2Health News:Allergies Might Trigger Depression 2Health News:Coupon Site TrimBack.com Adds 7000th Online Store 2Health News:Genes' Link to Certain Cancers Questioned 2
(Date:11/21/2014)...  Alere Inc. (NYSE: ALR ), a ... Juliet Cunningham as Vice President, Investor Relations. In ... driving communications with the investment community. "As ... to increase shareholder value, it is critical that we ... Chief Executive Officer. "We are delighted that Juliet ...
(Date:11/21/2014)... SARASOTA, Fla. , Nov. 21, 2014   ... ) announced that the Company is scheduled to present ... San Francisco, CA on January 12-14, ... PhD, Chairman and CEO of Rock Creek Pharmaceuticals, will ... small molecule cholinergic agonist which exhibits anti-inflammatory pharmacological characteristics. ...
(Date:11/21/2014)... , 21. November 2014 /PRNewswire/ ... hat heute bekannt gegeben, dass die ... EMA) die Kennzeichnung als Orphan-Medizinprodukt an ... des Unternehmens zur Behandlung von Fibrodysplasia ... seltene, stark beeinträchtigende genetische Krankheit, die ...
Breaking Medicine Technology:Alere Appoints Juliet Cunningham to Lead Investor Relations 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3
Female Mini-VEST Seamless, Front Closure...
Male Support Brief...
For Lipoplasty or surgery of abdomen, flanks and midriff...
Select Support Brief...
Medicine Products: